A clinical trial is a significant accomplishment for Medicortex
Medicortex was founded by Dr. Adrian Harel in Turku in 2014
Medicortex Finland is dedicated to improving the diagnosis, treatment and prevention of acute neurodegenerative conditions and is currently focused on developing a novel multiplex treatment for traumatic brain injury.
“Collecting and testing human samples in a clinical trial is a significant accomplishment for Medicortex, and represents a meaningful step forward in the development of a fast inexpensive diagnostic kit for head injury,” said Dr. Adrian Harel, Chairman and Chief Executive Officer of Medicortex Finland.
“Brain injury is a devastating condition with mortality if not diagnosed. The opportunity to develop the first portable non-invasive kit for head injury and concussion to help the patients and families that so desperately need it is remarkable.”
Offices are located at the Biohautomo of Turku Science Park.
20 September 2018
Bioagora 2018 (Copenhagen)
19 September 2018
STZ OcuTox: Drug development know-how